Dividend Yield: 14.2%
Market Cap: $850 million

You would never expect a small-cap biotech firm to have a monster dividend yield, but PDL Biopharma (PDLI) is a delightful exception.

The company engages in the management of "antibody humanization patents," as well as royalty assets and license agreements with various biotechnology and pharmaceutical firms. In a nutshell, the process of "humanization" helps makes medications compatible with the biology of men and women so that they work properly.

Continue reading Dividend Stock #4: PDL Biopharma (PDLI)

Dividend Stock #4: PDL Biopharma (PDLI) originally appeared on BloggingStocks on Sun, 14 Mar 2010 10:00:00 EST. Please see our terms for use of feeds.

Dividends are an often overlooked but crucial part of a successful retirement strategy. These quarterly offerings can provide a regular "paycheck" for retirees -- especially when the company is a high-yielding blue chip with a track record of boosting its dividend year after year.

But dividends don't just have to be a quiet way to grow your nest egg. They can really supercharge your returns when you buy into a great stock that also happens to be cash-rich. On top of the appreciation you see in your shares, you'll also get a great bonus checked mailed four times a year -- or more, depending on the dividend schedule.

Continue reading Nine Little-Known Dividend Stocks with Big Yields

Nine Little-Known Dividend Stocks with Big Yields originally appeared on BloggingStocks on Sat, 13 Mar 2010 09:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Jefferies downgraded shares of Thornburg Mortgage (NYSE: TMA) to Hold from Buy to reflect the ongoing dislocation of the mortgage markets and lowered their target to $3.75 from $14. While they believe Thornburg will probably survive its current liquidity crisis, they think the company's capital structure will be impaired further.
  
• JP Morgan downgraded Whirlpool (NYSE: WHR) to Underweight from Neutral, citing valuation, higher steel prices, the difficult macro environment and competition.
  
• Stephens cut Jackson Hewitt (NYSE: JTX) to Equal Weight from Overweight to reflect the company's recent results and concerns over the issues that have impacted the basic business.

• Merrill lowered Bank of Montreal (NYSE: BMO) to Sell from Neutral.
  
• Lehman downgraded PDL BioPharma (NASDAQ: PDLI) to Equal Weight from Overweight.
  
• Friedman Billings downgraded Tessera (NASDAQ: TSRA) to Market Perform from Outperform.

Analyst downgrades: Thornburg Mortgage, Whirlpool, Jackson Hewitt originally appeared on BloggingStocks on Wed, 05 Mar 2008 11:53:00 EST. Please see our terms for use of feeds.

PDL BioPharma (NYSE: PDLI) announced it will no longer actively pursue the sale of the company or its biotechnology discovery and development assets.

PDLI is recently down $2.96 to $12.88 in pre-open trading.

PDLI overall option implied volatility of 41 is above its 26-week average of 37 according to Track Data, suggesting slightly larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Option update: PDL BioPharma no longer pursuing sale of company originally appeared on BloggingStocks on Wed, 05 Mar 2008 09:30:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• JP Morgan upgraded shares of UBS (NYSE: UBS) to Neutral from Underweight as they believe the company can start fresh after yesterday's pre-announcement.
  
• Banc of America upgraded shares of ProLogis (NYSE: PLD) and AMB Property (NYSE: AMB) to Buy from Neutral to reflect their positive outlook on global industrial REITs and believes they are positioned to benefit from global demand for industrial space.
  
• Navteq Corporation (NYSE: NVT) was upgraded at Deutsche Bank to Hold from Sell to reflect the acquisition by Nokia Corporation (NYSE: NOK).
  
• Wachovia raised shares of PDL BioPharma Inc (NASDAQ: PDLI) to Outperform from Market Perform following the CEO resignation and potential sale of the company.

• Thor Industries (NYSE: THO) was upgraded to Buy from Gradually Accumulate at Soleil.
  
• Gabelli upgraded Hershey Company (NYSE: HSY) to Hold from Sell.
  
• Forest Laboratories (NYSE: FRX) was upgraded at Citigroup to Hold from Sell.
  
• Roth Capital upgraded Conexant Systems (NASDAQ: CNXT) to Hold from Sell.

Analyst upgrades: UBS, PLD, AMB, NVT and PDLI originally appeared on BloggingStocks on Tue, 02 Oct 2007 10:50:00 EST. Please see our terms for use of feeds.

DOW JONES & COMPANY (NYSE: DJ)

Continue reading This week's rumor round-up: Will News Corp pull its offer for Dow Jones?

This week's rumor round-up: Will News Corp pull its offer for Dow Jones? originally appeared on BloggingStocks on Fri, 15 Jun 2007 15:30:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY: Advanced Medical (EYE) and PDL BioPharma (PDLI) topped today's list of downgrades.

• Merril Lynch, Citigroup, Credit Suisse and BMO Capital Markets all downgraded Advanced Medical Optics, Inc. (NYSE:EYE) after the company's product recall.
• First Albany downgraded PDL BioPharma, Inc. (NASDAQ:PDLI) to Underperform from Neutral after news of Hoffman-LaRoche (RHHBY) discontinuing the co-development of Daclizumab for organ transplant patients.

OTHER DOWNGRADES:

• LongBow Research downgraded The Black & Decker Corp. (NYSE:BDK) to Neutral from Buy, citing slowing fundamentals as well as increased competition for the rationale.
• Credit Suisse downgraded Smurfit-Stone Container Corp. (NASDAQ:SSCC) to Neutral from Outperform citing container board prices that are near peak levels.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst downgrades 11-22-06: Advanced Medical gets a quad downgrade originally appeared on BloggingStocks on Wed, 22 Nov 2006 11:40:00 EST. Please see our terms for use of feeds.